Thursday, October 11, 2012

Kobo to buy Aquafadas, get magazines, academic texts, comics and children's books in the process

Canadian-born, Japanese-owned e-reader maker Kobo announced its intentions to acquire digital publishing company Aquafadas today, an agreement that'll bring rich content like magazines, academic texts, comics and children's books, amongst others, to Kobo users. The deal also builds out Kobo's self-publishing offering, bringing more tools to the table, along with additional languages like German, French, Italian, Portuguese and Dutch. Kobo's also taking the opportunity to announce exapanded offerings in New Zealand, thanks to partnerships with Booksellers NZ and The Paper Plus Group. Back in September, the company announced a trio of new devices set for release this month and next in the States.

Continue reading Kobo to buy Aquafadas, get magazines, academic texts, comics and children's books in the process

Filed under:

Kobo to buy Aquafadas, get magazines, academic texts, comics and children's books in the process originally appeared on Engadget on Wed, 10 Oct 2012 10:47:00 EDT. Please see our terms for use of feeds.

Permalink   |   | Email this | Comments


Source: http://feeds.engadget.com/~r/weblogsinc/engadget/~3/yUYptWbyimU/

minka kelly James Holmes court Rupert Sanders bachelorette penn state Ernie Els Teen Choice Awards 2012

ISS Robotic Arm Captures Dragon Capsule

The slowest space scene in Apollo 13 was when the command+service module separated from the 3rd stage, then flipped 180 degrees to dock with and extract the lunar module. The whole scene took a minute or so, with tense music accompaniment.

In reality it would've taken much longer; on Apollo 17 it took 15 minutes just to dock, and some more time to check everything before extraction. On Apollo 14 it took six attempts and over two hours, before they finally docked successfully. Apollo 13 is one of my favourite movies, but it's still Hollywood entertainment, with pacing and embellishments to match, and not a documentary or realistic depiction of events.

The video capture of Dragon is far more like 2001, for example the two scenes where space pods are deployed. In both cases you can say the model shots lasted way too long, but that's Teancum's point: it's reality, or pretty close to it in the case of 2001, so naturally they are both "slow".

Source: http://rss.slashdot.org/~r/Slashdot/slashdotScience/~3/dqPPqdEL_Fo/iss-robotic-arm-captures-dragon-capsule

cate blanchett nfl news tebow tebow jets romney etch a sketch jeb bush sherry arnold

Wednesday, January 25, 2012

Supreme Court rules on GPS tracking, but punts on larger issues

By Bob Sullivan

Monday?s Supreme Court ruling invalidating a conviction based on evidence gained by GPS tracking of a suspect's car might seem like a victory for privacy advocates. But on the critical issues of privacy and Fourth Amendment rights, the majority of the court actually punted.?

The unanimous opinion issued Monday morning is among the first in which the Supreme Court has decided a case at the thorny 21st-Century intersection of law, technology and privacy.? Police in Washington, D.C., had tracked a suspect by placing a tiny GPS device on his car, then tracking his movements for about a month. While the trial court held that evidence obtained through the GPS amounted to surveillance of the suspect's movements through public spaces, an appeals court ruled that it constituted an illegal search and seizure and a violation of Fourth Amendment rights.? The Supreme Court affirmed the decision.?

There was a remarkable amount of disagreement, however, in this unanimous decision. The court issued perhaps the narrowest ruling possible -- essentially that placement of the GPS on the car constituted a violation of property and effects rights, akin to trespassing, therefore spoiling any evidence garnered through the process.? Left undecided: What rights do citizens have when law enforcement uses other technological methods to track their whereabouts?

Justice Sonia Sotomayor, while concurring with the decision, delivered a separate opinion dripping with disappointment.

"With increasing regularity, the government will be capable of duplicating the monitoring undertaken in this case by enlisting factory- or owner-installed vehicle tracking devices or GPS-enabled smartphones. In cases of electronic or other novel modes of surveillance that do not depend upon a physical invasion on property, the majority opinion?s trespassory test may provide little guidance," she wrote.

Electronic law expert Mark Rasch, former head of the Justice Department's Computer Crime unit, said the opinion has "almost given carte blanche to law enforcement to go ahead and try to find their way around" the ruling, such as enlisting the help of cell phone providers to track citizens in their cars.

Sotomayer clearly regretted that the majority did not take the opportunity to make a more definitive ruling on privacy and Fourth Amendment rights, Rasch said. In her opinion she raised the complex issue of law enforcement agencies increasingly using private firms to aid in surveillance and evidence gathering. Rules governing evidence originally obtained by third parties are unclear, but generally offer fewer rights that rules governing law enforcement investigative techniques.

"This approach is ill suited to the digital age, in which people reveal a great deal of information about themselves to third parties in the course of carrying out mundane tasks," Sotomayer wrote. "People disclose the phone numbers that they dial or text to their cellular providers; the URLs that they visit and the e-mail addresses with which they correspond to their Internet service providers; and the books, groceries, and medications they purchase to online retailers. ? I for one doubt that people would accept without complaint the warrantless disclosure to the government of a list of every website they had visited in the last week, or month, or year."

Justice Samuel Alito also seemed frustrated by the court's failure to take on the deeper issues raised in the GPS tracking case.

"(This opinion) largely disregards what is really important (the use of a GPS for the purpose of long-term tracking) and instead attaches great significance to something that most would view as relatively minor -- attaching to the bottom of a car a small, light object that does not interfere in any way with the car?s operation,? he wrote in a concurring opinion. ?"By contrast, if long-term monitoring can be accomplished without committing a technical trespass ? suppose, for example, that the federal government required or persuaded auto manufacturers to include a GPS tracking device in every car ? the court?s theory would provide no protection."

The Justice Department had asked for even more sweeping evidence-gathering rights. It argued that placement of the GPS device on the suspect's car was akin to other forms of electronic evidence-gathering that the court has already allowed. The most analogous situation, the Justice Department argued, was placing a homing beacon, or "beeper," in a device that is given to a suspect ? for example, in the case cited by Justice, when illicit chemicals with a beeper attached were sold by a cooperating witness to a suspect.? But such beepers are placed into property with the permission of a third party and then accepted voluntarily by a suspect. That differs greatly from law enforcement attaching a gadget to a suspect's car, the court found. That makes the act less like surveillance and more akin to a search, affording it Fourth Amendment requirements.

"The government physically occupied private property for the purpose of obtaining information," Justice Antonin Scalia wrote. "We have no doubt that such a physical intrusion would have been considered a 'search' within the meaning of the Fourth Amendment when it was adopted."

Scalia was comfortable stopping there.

"It may be that achieving the same result through electronic means, without an accompanying trespass, is an unconstitutional invasion of privacy, but the present case does not require us to answer that question," he wrote, in a direct answer to Sotomayer's complaint. "There is no reason for rushing forward to resolve them here."

Rasch found deep faults in Scalia's logic. Police "attach" things to citizens' automobiles all the time. Parking tickets, for example, or chalk marks as a reminder to meter maids that cars may have exceeded hourly requirements. The act of installing something on a car is not itself trespassing, he argued ? it?s the act of using such a device to track a citizens' movement over time without a warrant that raises constitutional issues.?

"'Hands off my car,' is the best way I can put this ruling," he said, adding that he thought the court had failed by issuing such a narrow ruling.

"They've avoided the issue. They were asked to address the Fourth Amendment issues, and they decided a trespassing case," he said. "You don't need the Supreme Court for that."?

?

?Don't miss the next Red Tape:
*Get Red Tape headlines on your Facebook Wall
*Follow Bob on Twitter.?
*Get an e-mail newsletter with Red Tape stories?(requires Newsvine registration).

Source: http://redtape.msnbc.msn.com/_news/2012/01/23/10217642-supreme-court-rules-on-gps-tracking-but-punts-on-larger-issues

melanie amaro new air jordans the patriot jeff dunham night at the museum young guns concord

LA detective in Simpson-Goldman murders dies at 70

Philip Vannatter, the Los Angeles police detective who served as a lead investigator in the 1994 murders of Nicole Brown Simpson and Ronald Goldman, has died in Southern California, according to his brother. He was 70.

Vannatter died Friday at a Santa Clarita hospital of complications from cancer, his brother Joe Vannatter told The Associated Press on Sunday.

He was among the first detectives on the scene at former football star O.J. Simpson's mansion in June 1994, following the stabbing deaths of Simpson's wife Nicole and her friend, Ron Goldman. Vannatter testified at the murder trial, at which Simpson was acquitted.

In 1977, Vannatter conducted the investigation that led to the arrest of film director Roman Polanski on charges he drugged and had unlawful sex with a 13-year-old girl.

A 28-year veteran with the LAPD, where he spent most of his career as a homicide detective, Vannatter retired from the force in 1995 but continued on as a consultant for cold case murders.

"He was a very devoted detective," Joe Vannatter said, adding his brother worked some 250 murder cases in his career. "The last time I saw him he had gotten a call from LAPD that they solved a homicide he was involved in 30 years ago. He took great pride in that."

Vannatter arrested Polanski in the lobby of the Beverly Wilshire hotel in Beverly Hills, kicking off an international legal saga that escalated when the director fled to France after he was convicted. As he put the cuffs on, Vannatter said he found Polanski was clutching a Quaalude, the drug he was accused of giving his young victim.

Vannatter had planned to retire in late 1994 but instead spent more than a year in the middle of the Simpson trial. Along with fellow detective Mark Furman, Vannatter's name often featured in headlines and his face was a common sight on cable news shows.

Defense lawyers took aim at Vannatter's truthfulness, suggesting police set out to get Simpson as soon as his ex-wife was found slain.

The defense argued that the search of Simpson's estate was illegal and that all evidence seized ? including a bloody glove, bloody socks and bloody drops ? should be thrown out.

On the witness stand, Vannatter sharply defended the actions of detectives at the crime scene. Two judges upheld the search on the basis of Vannatter's and other detectives' testimony that they were trying to inform Simpson of the death and that it became an emergency after blood was discovered on Simpson's Bronco and they feared people in Simpson's house might be injured.

  1. Only on msnbc.com

    1. After drone hit on al-Qaida planner, is Zawahiri next?
    2. Syria's capital delivers show of support for Assad
    3. 'Miracle' baby born from single frozen sperm
    4. China braces for Year of the Dragon travel rush
    5. Should couples share passwords?
    6. 1,137 dogs rescued from Chinese dinner table
    7. Poker players sue over online cheating scheme

"I don't think anybody's ever been in the news like that. ... It's history now. Obviously we're disgusted about what happened," Vannatter said in 1995 of Simpson's acquittal.

Joe Vannatter said his brother took the spotlight ? and the criticisms ? that came with the Simpson trial in stride.

"He was very upbeat and he knew he did the right thing," Joe Vannatter said about his brother's involvement in the case. "He had such thick skin. They felt that they had the right person that committed this horrendous crime."

During retirement Vannatter lived part time on a farm in Indiana, where he served for four years as a deputy sheriff in the town of Vevay, pop. 1,683.

Before joining law enforcement, the West Virginia native served in the U.S. Army.

Besides his brother, Vannatter is survived by his wife, Rita; their daughter, Donna; their son, Matthew, an LAPD officer; and five grandchildren.

Services are planned for Wednesday at Forest Lawn Memorial Park in Hollywood. A fund has been established in Vannatter's name with the Los Angeles Police Memorial Foundation.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Source: http://www.msnbc.msn.com/id/46091699/ns/us_news/

st nicholas st nicholas mindy mccready mindy mccready cliff harris cliff harris josh turner

Tuesday, January 24, 2012

Klum and Seal: 'We have decided to separate'

Dan Steinberg / AP

Heidi Klum and Seal confirmed Sunday that they are separating.

By Anna Chan

It's official: Supermodel and "Project Runway" host Heidi Klum and singer Seal are officially separating after seven years together.

TMZ first reported on Saturday that Klum was going to file for divorce as early as this week. On Sunday night, the pair confirmed the split in a statement to People.

"While we have enjoyed seven very loving, loyal and happy years of marriage, after much soul-searching we have decided to separate," the?pair told the magazine.?

"We have had the deepest respect for one another throughout our relationship and continue to love each other very much, but we have grown apart. This is an amicable process and protecting the well-being of our children remains our top priority, especially during this time of transition."

Klum and Seal have three biological children together, and the singer adopted the model's eldest daughter, Leni, from a previous relationship.

"They've had a very rough road lately," a friend of the couple told Us Weekly on Saturday.?"They're either madly in love or having? crazy fights."

More in TODAY entertainment:

Source: http://todayentertainment.today.msnbc.msn.com/_news/2012/01/23/10213217-heidi-klum-and-seal-we-have-decided-to-separate

best buy black friday frys ad a very gaga thanksgiving black friday walmart 2011 sams club dancing with the stars winner too short

Monday, January 23, 2012

Biomarkers in Cancer Research ? High Unmet Need in Cervical ...

Biomarkers in Cancer Research ? High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth?

Cancer Research?Market?

GBI Research, the leading business intelligence provider, has released its latest report, ?Biomarkers in Cancer Research ? High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth? that provides key data, information and analysis of the major trends and issues affecting the biomarkers in cancer research. The report provides a comprehensive insight into the history of biomarkers, its uses, efficiency as well as their limitations. The report also provides a detailed analysis of cancer biomarkers market characterization in terms of its market size, segmentation by key cancer types and the major market drivers and barriers. The report also talks about the patent landscape for cancer biomarkers and provides comprehensive analysis. The report also looks into the cancer biomarkers pipeline along with analysis on the pipeline by indication, phase of development and geography of development. The report also provides competitive landscape of the market that profiles key market players along with their brief business description, pipeline, major products and major M&A and partnership deals. The report also provides detailed analysis of major partnership deals that have taken place in the cancer biomarkers market since 2006 along with segmentation by number of deals per year, indication, deal type, geography and companies. In addition, the report also talks about the major M&A deals in the cancer biomarkers market since 2005 along with segmentation by value, geography and companies. Finally, the report provides the major conclusions from the report.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research?s team of industry experts.

Scope

The scope of the report includes:

  • Detailed overview of biomarkers in pharmaceutical industry along with their use, efficiency and limitation
  • Annualized market data from 2007 and forecast forward till 2016 along with segmentation by cancer types including breast cancer, colorectal cancer, prostate cancer, lung cancer, cervical cancer, head and neck cancer, pancreatic cancer, ovarian cancer and stomach cancer
  • Key market drivers and restraints shaping the cancer biomarkers market
  • Patent analysis of the cancer biomarkers along with segmentation by patent type, company and geography
  • Pipeline analysis of the cancer biomarkers along with segmentation by indication, phase and geography
  • Analysis of partnership deals from 2006 to 2010 along with segmentation by indication, deal type, geography and companies
  • Analysis of M&A deals from 2005 to 2010 along with segmentation by value geography and companies

Reasons to buy

The report will enhance your decision making capability. It will allow you to

  • Develop better strategies for cancer biomarkers research by understanding the market dynamics of the cancer biomarker research industry
  • Develop market-entry and market expansion strategies by identifying the key cancer areas for high growth and high opportunities
  • Understand the factors shaping the cancer biomarkers research market
  • Reinforce R&D pipeline by identifying the key biomarker tests which can provide more accurate and early diagnosis of cancer
  • Identify the key players best positioned to take the advantage of the opportunities in the global cancer biomarkers research market
  • Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.

Table of Contents

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7

2 Introduction 8
2.1 GBI Research Report Guidance 8

3 Biomarkers Overview 9
3.1 History of Cancer Biomarkers 9
3.2 Use of Cancer Biomarkers 10
3.2.1 Screening and Early Detection 10
3.2.2 Diagnosis of Cancer 11
3.2.3 Prognosis and Measuring Effectiveness of Treatment 12
3.2.4 Detecting Recurrent Cancer 13
3.3 Efficiency of Cancer Biomarkers 14
3.3.1 Speed and Accuracy of Diagnosis 14
3.3.2 Optimize Costs 14
3.3.3 Increased Survival Rates 15
3.3.4 Non Invasive Techniques 15
3.4 Limitations of Cancer Biomarkers 16
3.5 Key Takeaway 16

4 Market Characterization 17
4.1 Market Overview 17
4.2 Market Size and Forecasts 17
4.2.1 Segmentation by Indication 19
4.3 Drivers and Restraints 29
4.3.1 Market Drivers 30
4.3.2 Market Barriers 31
4.4 Key Takeaway 31

5 Patent Analysis 32
5.1 Segmentation by Patent Type 32
5.2 Segmentation by Company 33
5.3 Segmentation by Geography 34
5.4 Key Takeaway 35

6 Pipeline Analysis 36
6.1 Biomarkers in Cancer Research Pipeline by Indication 36
6.2 Biomarkers in Cancer Research Pipeline by Phase 37
6.3 Biomarkers in Cancer Research Pipeline by Geography 38
6.4 Key Takeaway 38

7 Competitive Landscape 39
7.1 Clarient, Inc. 39
7.1.1 Business Description 39
7.1.2 Pipeline 39
7.1.3 Major Products 40
7.1.4 Partnership and M&A Deals 40
7.2 Qiagen N.V. 41
7.2.1 Business Description 41
7.2.2 Pipeline 42
7.2.3 Major Products 42
7.2.4 Partnership and M&A Deals 44
7.3 Laboratory Corporation of America Holdings 46
7.3.1 Business Description 46
7.3.2 Pipeline 46
7.3.3 Major Products 46
7.3.4 Partnership and M&A Deals 47
7.4 bioMerieux S.A. 49
7.4.1 Business Description 49
7.4.2 Pipeline 49
7.4.3 Major Products 49
7.4.4 Partnership and M&A Deals 50
7.5 Biomoda, Inc. 52
7.5.1 Business Description 52
7.5.2 Pipeline 52
7.5.3 Major Products 52
7.5.4 Partnership and M&A Deals 53
7.6 Exiqon A/S 53
7.6.1 Business Description 53
7.6.2 Pipeline 54
7.6.3 Major Products 54
7.6.4 Partnership and M&A Deals 55
7.7 Beckman Coulter, Inc. 55
7.7.1 Business Description 55
7.7.2 Pipeline 55
7.7.3 Major Products 56
7.7.4 Partnership and M&A Deals 56
7.8 A&G Pharmaceutical, Inc. 57
7.8.1 Business Description 57
7.8.2 Pipeline 57
7.8.3 Major Products 58
7.8.4 Partnership and M&A Deals 58
7.9 AdnaGen AG 59
7.9.1 Business Description 59
7.9.2 Pipeline 59
7.9.3 Major Products 59
7.9.4 Partnership and M&A Deals 60
7.10 Rosetta Genomics, Ltd. 61
7.10.1 Business Description 61
7.10.2 Pipeline 62
7.10.3 Major Products 62
7.10.4 Partnership and M&A Deals 63

8 Deals Analysis 64
8.1 Partnership Deals 64
8.1.1 Partnership Deals by Year 64
8.1.2 Partnership Deals by Indication 65
8.1.3 Partnership Deals by Deal Type 66
8.1.4 Partnership Deals by Geography 67
8.1.5 Partnership Deals by Companies 68
8.2 M&A Landscape 69
8.2.1 M&A Deals by Value 69
8.2.2 M&A Deals by Geography 70
8.2.3 M&A Deals by Companies 71
8.2.4 Top Five M&A Deals by Value 71
8.3 Key Takeaway 73

9 Conclusion 74

10 Appendix 75
10.1 Market Definitions 75
10.2 Abbreviations 75
10.3 Research Methodology 76
10.3.1 Coverage 76
10.3.2 Secondary Research 77
10.3.3 Primary Research 77
10.3.4 Expert Panel Validation 77
10.4 Contact Us 78
10.5 Disclaimer 78
10.6 Sources 78

List of Table:
Table 1: Biomarkers in Cancer Research, Global, Cancer Biomarkers Market Revenues ($bn), 20072016 18
Table 2: Biomarkers in Cancer Research, Global, Breast Cancer Biomarkers Market Revenues ($m), 20072016 20
Table 3: Biomarkers in Cancer Research, Global, Prostate Cancer Biomarkers Market Revenues ($m), 20072016 21
Table 4: Biomarkers in Cancer Research, Global, Lung Cancer Biomarkers Market Revenues ($m), 20072016 22
Table 5: Biomarkers in Cancer Research, Global, Colorectal Cancer Biomarkers Market Revenues ($m), 20072016 23
Table 6: Biomarkers in Cancer Research, Global, Cervical Cancer Biomarkers Market Revenues ($m), 20072016 24
Table 7: Biomarkers in Cancer Research, Global, Head & Neck Cancer Biomarkers Market Revenues ($m), 20072016 25
Table 8: Biomarkers in Cancer Research, Global, Pancreatic Cancer Biomarkers Market Revenues ($m), 20072016 26
Table 9: Biomarkers in Cancer Research, Global, Ovarian Cancer Biomarkers Market Revenues ($m), 20072016 27
Table 10: Biomarkers in Cancer Research, Global, Stomach Cancer Biomarkers Market Revenues ($m), 20072016 28
Table 11: Biomarkers in Cancer Research, Global, Patent Analysis by Company, 2010 33
Table 12: Biomarkers in Cancer Research, Global, Patent Analysis by Territory, 2010 34
Table 13: Biomarkers in Cancer Research, Global, Pipeline by Indication and Stage of Development, August 2010 36
Table 14: Biomarkers in Cancer Research, Clarient Pipeline, August 2010 39
Table 15: Biomarkers in Cancer Research, Clarient, Major M&A Deals, 20052010 40
Table 16: Biomarkers in Cancer Research, Clarient, Partnership Deals, 20062010 41
Table 17: Biomarkers in Cancer Research, Qiagen Pipeline, August 2010 42
Table 18: Biomarkers in Cancer Research, Qiagen, Major M&A Deals, 20052010 44
Table 19: Biomarkers in Cancer Research, Qiagen, Partnership Deals, 20062010 45
Table 20: Biomarkers in Cancer Research, Laboratory Corporation of America Holdings, Pipeline, August 2010 46
Table 21: Biomarkers in Cancer Research, Laboratory Corporation of America Holdings, Major M&A Deals, 20052010 47
Table 22: Biomarkers in Cancer Research, Laboratory Corporation of America Holdings, Partnership Deals, 20062010 48
Table 23: Biomarkers in Cancer Research, bioMerieux Pipeline, August 2010 49
Table 24: Biomarkers in Cancer Research, bioMerieux, Major M&A Deals, 20052010 50
Table 25: Biomarkers in Cancer Research, bioMerieux, Partnership Deals, 20062010 51
Table 26: Biomarkers in Cancer Research, Biomoda Pipeline, August 2010 52
Table 27: Biomarkers in Cancer Research, Biomoda, Partnership Deals, 20062010 53
Table 28: Biomarkers in Cancer Research, Exiqon Pipeline, August 2010 54
Table 29: Biomarkers in Cancer Research, Exiqon, Major M&A Deals, 20052010 55
Table 30: Biomarkers in Cancer Research, Beckman Coulter Pipeline, August 2010 55
Table 31: Biomarkers in Cancer Research, Beckman Coulter, Major M&A Deals, 20052010 56
Table 32: Biomarkers in Cancer Research, Beckman Coulter, Partnership Deals, 20062010 57
Table 33: Biomarkers in Cancer Research, A&G Pharmaceutical Pipeline, August 2010 57
Table 34: Biomarkers in Cancer Research, A&G Pharmaceutical, Major M&A Deals, 20052010 58
Table 35: Biomarkers in Cancer Research, AdnaGen Pipeline, August 2010 59
Table 36: Biomarkers in Cancer Research, AdnaGen, Major M&A Deals, 20052010 60
Table 37: Biomarkers in Cancer Research, AdnaGen, Partnership Deals, 20062010 61
Table 38: Biomarkers in Cancer Research, Rosetta Genomics Pipeline, August 2010 62
Table 39: Biomarkers in Cancer Research, Rosetta Genomics, Partnership Deals, 20062010 63
Table 40: Biomarkers in Cancer Research, Global, Partnership Deals by Indication, 20062010 65

List of Charts:
Figure 1: Biomarkers in Cancer Research, Global, Cancer Biomarkers Market Revenues ($bn), 20072016 17
Figure 2: Biomarkers in Cancer Research, Global, Market Segmentation by Indication, 2009 19
Figure 3: Biomarkers in Cancer Research, Global, Breast Cancer Biomarkers Market Revenues ($m), 20072016 20
Figure 4: Biomarkers in Cancer Research, Global, Prostate Cancer Biomarkers Market Revenues ($m), 20072016 21
Figure 5: Biomarkers in Cancer Research, Global, Lung Cancer Biomarkers Market Revenues ($m), 20072016 22
Figure 6: Biomarkers in Cancer Research, Global, Colorectal Cancer Biomarkers Market Revenues ($m), 20072016 23
Figure 7: Biomarkers in Cancer Research, Global, Cervical Cancer Biomarkers Market Revenues ($m), 20072016 24
Figure 8: Biomarkers in Cancer Research, Global, Head & Neck Cancer Biomarkers Market Revenues ($m), 20072016 25
Figure 9: Biomarkers in Cancer Research, Global, Pancreatic Cancer Biomarkers Market Revenues ($m), 20072016 26
Figure 10: Biomarkers in Cancer Research, Global, Ovarian Cancer Biomarkers Market Revenues ($m), 20072016 27
Figure 11: Biomarkers in Cancer Research, Global, Stomach Cancer Biomarkers Market Revenues ($m), 20072016 28
Figure 12: Biomarkers in Cancer Research, Market Drivers and Restraints, August 2010 29
Figure 13: Biomarkers in Cancer Research, Global, Patent Analysis by Patent Type, 2010 32
Figure 14: Biomarkers in Cancer Research, Global, Patent Analysis by Company, 2010 33
Figure 15: Biomarkers in Cancer Research, Global, Patent Analysis by Territory, 2010 34
Figure 16: Biomarkers in Cancer Research, Global, Pipeline by Indication (%), August 2010 36
Figure 17: Biomarkers in Cancer Research, Global, Pipeline by Phase of Development (%), August 2010 37
Figure 18: Biomarkers in Cancer Research, Global, Pipeline by Geography (%), August 2010 38
Figure 19: Biomarkers in Cancer Research, Global, Partnership Deals by Year, 20062010 64
Figure 20: Biomarkers in Cancer Research, Global, Partnership Deals by Indication, 20062010 65
Figure 21: Biomarkers in Cancer Research, Global, Partnership Deals by Deal Type, 20062010 66
Figure 22: Biomarkers in Cancer Research, Global, Partnership Deals by Geography, 20062010 67
Figure 23: Biomarkers in Cancer Research, Global, Partnership Deals by Companies, 20062010 68
Figure 24: Biomarkers in Cancer Research, Global, M&A Deals by Value (%), 20052010 69
Figure 25: Biomarkers in Cancer Research, Global, M&A Deals by Geography (%), 20052010 70
Figure 26: Biomarkers in Cancer Research, Global, M&A Deals by Companies (%), 20052010 71

Source: http://www.wpt9.com/biomarkers-in-cancer-research-high-unmet-need-in-cervical-cancer-and-lung-cancer-to-drive-growth/

dark energy dark energy sherri shepherd sherri shepherd sean avery east river east river

Kristin Cavallari, Jay Cutler Confirm Pregnancy

Former 'Hills' star and her football player fiancé expecting first child together.
By Jocelyn Vena


Kristin Cavallari
Photo: Michael Tran/FilmMagic

And then there were three. Former "Hills" star Kristin Cavallari and her football-playing fiancé, Jay Cutler, have confirmed that they are soon going to be parents.

"We are thrilled to announce we are expecting our first child together," the couple said in a statement to People.com. "It's an amazing time in our life and we can't wait to meet the new addition to our growing family."

The road to parenthood has had its ups and downs for the duo. After initially getting engaged in April 2011, the soon-to-be parents called it off in July, reportedly while they were knee-deep in planning their wedding.

However, after several months apart, the couple confirmed that they were once again engaged in November. The football player asked the former reality starlet to marry him with a 5.2-carat engagement ring.

"She is really happy. She is in the early stages, but she can't wait to be a mom," a source told USmagazine.com. "They have just bought a house in Tennessee and can't wait to start their family."

In an interview with the magazine, Cavallari opened up a bit about her on-again, off-again relationship with Cutler. "The past year has been interesting," she said in December, shortly after they got back together. "There have been a lot of ups and downs, but overall it's been great. We're just enjoying being engaged," she added. "We were definitely planning the first time, but I can't plan the same wedding. I need to do something entirely different."

Before settling down with Cutler, Cavallari had a reputation for being quite the man-eater. On her stints on both "Laguna Beach" and "The Hills," the small screen's biggest vixen hooked up with Justin Bobby Brescia, Brody Jenner and Stephen Colletti.

Related Videos Related Photos

Source: http://www.mtv.com/news/articles/1677700/kristin-cavallari-pregnant-jay-cutler.jhtml

jerry angelo work it amy chua iowa gop gloria steinem forgetting sarah marshall meteor shower tonight